Posted on April 30th, 2009 by Health News
Results from two prospective, double-blind placebo controlled multi-center studies in patients with cervical dystonia and blepharospasm, and pooled European efficacy and safety data in patients with focal dystonia and upper limb spasticity will be presented at the American Academy of Neurology’s (AAN) 61st annual meeting in Seattle. The studies were sponsored by Merz Pharmaceuticals, which [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
Researchers from Dendreon Corporation (Nasdaq: DNDN) presented preclinical data demonstrating the potential of D-3263, Dendreon’s orally bioavailable small molecule, which targets TRPM8 (a transmembrane cation channel protein), to treat benign prostatic hyperplasia (BPH). D-3263 demonstrated the ability to reduce BPH alone and in combination with finasteride, a current treatment for BPH.
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
Endo Pharmaceuticals (Nasdaq: ENDP) released new long-term clinical trial data in men with hypogonadism who were treated for 21 months with testosterone undecanoate (NEBIDO(R) — 750 mg) injection, a long-acting testosterone replacement therapy in development in the U.S. for treatment of hypogonadism. Results showed that average testosterone levels were maintained within the normal range [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
Ocera Therapeutics, Inc., a privately held biopharmaceutical company, announced that data from its phase 2 study of AST-120 for the treatment of patients with low-grade hepatic encephalopathy was presented April 25th at the 44th Annual Meeting of the European Association for the Study of Liver Disease (EASL) in Copenhagen. The study showed that AST-120 was [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
Wyeth Pharmaceuticals has announced that the European Commission has granted marketing authorization for Conbriza (bazedoxifene), a selective estrogen receptor modulator (SERM), for the treatment of postmenopausal osteoporosis in women at increased risk of fracture.
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
The Food and Drug Administration issued a final rule today that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings about potential safety risks, such as internal bleeding and liver damage, associated with the use of these popular drugs. Products covered by the FDA action [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
The Royal Pharmaceutical Society is launching new tools to provide pharmacists with the professional support and information they need to implement the Responsible Pharmacist regulations that come into force on 1 October 2009. All practising pharmacists and pre-registration trainees will receive the Responsible Pharmacist Toolkit, along with new Professional Standards and Guidance on [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
The Royal Pharmaceutical Society of Great Britain is reiterating to pharmacists the need to adhere to its practice guidance regarding the sale of orlistat, a drug which can only be sold to patients who have undergone a consultation, and who have a Body Mass Index (BMI) of 28 or higher. [...]
No Comments »
Filed under: Pharmacy News
Posted on April 30th, 2009 by Health News
The Royal Pharmaceutical Society responded to concerns about the human swine flu virus H1N1 and stressed the vital role pharmacists play in public health. The Society’s Director of Policy and Communications David Pruce said: “At present, we are keeping a watching brief on the situation. Should the need arise, pharmacists will [...]
No Comments »
Filed under: Pharmacy News
